No Data
No Data
Analysts' Opinions Are Mixed on These Healthcare Stocks: AstraZeneca (GB:AZN), CSL (OtherCMXHF) and UCB SA (GB:0NZT)
AstraZeneca (AZN) Gets a Buy From Goldman Sachs
Reported Friday, FDA Approves Daiichi Sankyo And AstraZeneca's DATROWAY AS A New Treatment Option For HR Positive, HER2 Negative Breast Cancer In The U.S.
Trinasolar Powers AstraZeneca's Sustainability Vision With Cutting-Edge Solar Carpark Rooftop Install
BofA Securities Maintains AstraZeneca(AZN.US) With Buy Rating, Announces Target Price $91.7
Bank of America Securities Remains a Buy on AstraZeneca (AZN)
loading...